Clients News • MC Services corporate website
paged,page-template-default,page,page-id-5522,paged-12,page-paged-12,bridge-core-2.1.4,qode-listing-1.0.1,qode-social-login-1.0,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,paspartu_enabled,qode_grid_1400,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-20.1,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-6.5.0,vc_responsive




  • Imcyse SA: Imcyse Enters into Research Collaboration and License Agreement for its ImotopeTM Technology with Pfizer in Rheumatoid Arthritis
  • Imcyse SA: Imcyse Announces Start of Phase 1b/2a IMPACT Study in Patients with Recent Onset Type 1 Diabetes
  • XPhyto announces psychedelic pharmaceutical production agreement
  • CENTOGENE GmbH: CENTOGENE eröffnet Walk-In-Corona-Testzentrum am Flughafen Köln / Bonn
  • CEVEC and CARISMA Therapeutics sign license agreement for the use of CAP® Technology in anti-tumor cell therapies
  • CureVac and Rentschler Biopharma Ramp up Manufacturing of COVID-19 Vaccine, CVnCoV
  • AiCuris changes its legal form: AiCuris Anti-infective Cures GmbH becomes AiCuris AG
  • RedHill Biopharma Announces Positive DSMB Futility Review for Phase 2/3 COVID-19 Study of Opaganib
  • Marinomed Biotech AG announces preliminary revenues and confirms outlook for 2020
  • RedHill Biopharma Further Expands Opaganib Manufacturing Capacity for COVID-19 with Cosmo Pharmaceuticals